Androgenetic alopecia in men: The scale of the problem and prospects for treatment

International Journal of Clinical Practice

Volumn 53, Issue 1, 1999, Pages 50-53

  Rushton, D Hugh ^a  

^a 24 Harmont House ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE;

AGING; HUMAN; MALE; MALE TYPE ALOPECIA; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SHORT SURVEY;

ADULT; ALOPECIA; ANTIHYPERTENSIVE AGENTS; BODY IMAGE; ENGLAND; ENZYME INHIBITORS; FINASTERIDE; HUMANS; MALE; MIDDLE AGED; MINOXIDIL; QUALITY OF LIFE; VASODILATOR AGENTS;

EID: 0032970834     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (35)

1. Giacometti L. Facts, legends and myths about the scalp throughout history. Arch Dermatol 1967; 95: 629.
2. Kligman AM, Freeman B. History of baldness from magic to medicine. Clinics Dermatol 1988; 6: 83-88.
3. Burke KE. Hair loss: what causes it and what can be done about it. Postgrad Med 1989; 85(6): 52-58.
4. Bouhanna P. Traitements actuels des alopécies androgénétiques masculines et féminines (traitements hormonaux exceptés). Praxis 1997; 86: 996-999.
5. Hamilton JB. Patterned loss of hair in man: types and incidence. Ann NY Acad Sci 1951; 53: 708-728.
6. Norwood OT. Male pattern baldness: classification and incidence. Southern Med J 1975; 68: 1359-1370.
7. Ludwig E. Classification of the types of androgenic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977; 97: 247-254.
8. van Neste DJJ, Rushton DH. Hair problems in women. Clinics Dermatol 1997; 15: 113-125.
9. Trevisan M, Farinaro E, Krogh V, Jossa F et al. Baldness and coronary heart disease risk factors. J Clin Epidemiol 1993; 46: 1213-1218.
10. Herrara CR, D'Agostino RB, Gerstman B et al. Baldness and coronary heart disease rates in men from the Framingham study. Am J Epidemiol 1995; 142: 828-833.
11. Dawber RPR, Ebling FJG, Wojnarowska FT. Disorders of the hair. In: Champion RH, Burton JL, Ebling FJG, Eds. Textbook of dermatology, 5th edn, vol 4. Oxford: Blackwell Scientific Publications 1992; 2533-2577.
12. Simpson NB, Barth JH. Hair patterns: hirsuites and baldness. In: Rook A, Dawber R. Eds. Diseases of the hair and scalp. London: Blackwell Scientific Publications 1991; 113-135.
13. Duplechain G, White JA. Male pattern baldness. J Louisiana State Med Soc 1994; 146: 7-10.
14. Lesko SM, Rosenberg L, Shapiro S. A case-control study of baldness in relation to myocardial infarction in men. JAMA 1993; 269(8): 998-1003.
15. Setty LR. Hair patterns of the scalp of white and negro males. Am J. Phys Anthrop 1970; 33: 49-56.
16. Takashima T, Iju M, Sudo M. Alopecia androgenetica: its incidence in Japanese and associated conditions. In: Orfanos CE Montagna W, Stüttgen G, Eds. Hair research. Berlin: Springer-Verlag 1981; 287.
17. Rushton DH, Ramsay ID, Norris MJ, Gilkes JJH. Natural progression of male pattern baldness in young men. Clin Exp Dermatol 1991; 16: 188-192.
18. Bingham KD, Shaw DA. The metabolism of testosterone by human male scalp skin. J Endocrinol 1973; 57: 111-121.
19. Schweikert HU, Wilson JD, Regulation of human hair growth by steroid hormones. I. Testosterone metabolism in isolated hairs. J Clin Endocrinol Metab 1974; 38: 811-819.
20. Cash TF. The psychology of physical appearance: aesthetics, attributes, and images. In: Cash TF, Pruzinsky T, Eds. Body images: development, deviance and change. London and New York: Guilford Press, 1990.
21. Cash TF. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 1992; 26(6): 926-931.
22. Patzer GL. Psychologic and sociologic dimensions of hair: an aspect of the physical attractiveness phenomenon. Clinics Dermatol 1988; 6(4): 93-101.
23. Wells PA, Willmoth T, Russell RJH. Does fortune favour the bald? Psychological correlates of hair loss in males. Br J Psychol 1995; 86: 337-344.
24. Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol 1993; 29(4): 568-575.
25. Passchier J, Rijpma SE, Dutree-Meulenberg RO et al. Why men with hair loss go to the doctor. Psychol Rep 1989: 65(1): 323-330.
26. Rubin MB. Androgenetic alopecia: battling a losing proposition. Postgrad Med 1997; 102(2): 129-131.
27. Resnick HLP. Psychiatric observations on patients who seek and undergo hair transplantation. J Dermatol Surg Oncol 1997; 6: 1023-1025.
28. Olsen EA, Weiner MS, DeLong ER, Pinnell SR. Topical minoxidil in early male pattern baldness. J Am Acad Dermatol 1985; 13: 185-192.
29. Koperski JA, Orenberg EK, Wilkinson DI. Topical minoxidil therapy for androgenetic alopecia: a 30-month study. Arch Dermatol 1987: 123: 1483-1487.
30. Rietschel RL, Duncan SH. Safety and efficacy of topical minoxidil in the management of androgenetic alopecia. J Am Acad Dermatol 1987: 16: 677-685.
31. Savin RC. Use of topical minoxidil in the treatment of male pattern baldness. J Am Acad Dermatol 1987: 16: 696-704.
32. Rushton DH, Linger WP, Cotterill PC et al. Quantitative assessment of 2% topical minoxidil in the treatment of male pattern baldness. Clin Exp Dermatol 1989; 14: 40-46.
33. Price VH, Menefee E. Quantitative estimation of hair growth: comparative changes in weight and hair count with 5% and 2% minoxidil, placebo and no treatment. In: Van Neste DJ, Randall VA, Eds. Hair research for the next millennium. Amsterdam: Elsevier 1996; 67-71.
34. Bayne EK, Flanagan J. Einstein M et al. Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp. Personnal communication, 1998.
35. Kaufman K. Clinical studies on the effects of oral finasteride, a type II 5α-reductase inhibitor, on scalp hair in men with male patient baldness. In: Van Neste DJ, Randall VA. Eds. Hair research for the next millennium. Amsterdam: Elsevier 1996; 363-365.